Department of Thoracic Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
BMC Surg. 2022 May 14;22(1):180. doi: 10.1186/s12893-022-01628-6.
Although the risk calculator of the National Clinical Database (RC-NCD) has been widely used to predict the occurrence of mortality and major morbidity in Japan, it has not been demonstrated whether a correlation between the calculated RC-NCD risk score and the actual occurrence of mortality and severe morbidity exists.
The clinical data of 585 patients who underwent pulmonary resection for non-small cell lung cancer were collected, and the risk factors for postoperative morbidity were analyzed to verify the validity of the RC-NCD.
The coexistence of asthma (p = 0.02), nutrition lymphocyte ratio (p = 0.04), and pulmonary lobe (p < 0.01) were significant risk factors for postoperative morbidity in the present study, and the percent-predicted vital capacity (p < 0.01), pulmonary lobe (p = 0.03), and type of operative procedure (p = 0.01) were significant risk factors for severe postoperative morbidity. Furthermore, in patients received lobectomy, coexistence of asthma (p = 0.01) and pulmonary lobe (p < 0.01) were identified as significant risk factors for postoperative morbidity. Meanwhile, male sex (p = 0.01), high BMI (p < 0.01), low vital capacity (p = 0.04), and pulmonary lobe (p = 0.03) were identified as significant risk factors for severe postoperative morbidity.
Given that the pulmonary lobe was a significant risk factor for postoperative morbidity in patients received pulmonary resection and for severe postoperative morbidity in patients received lobectomy, the RC-NCD for postoperative morbidity needs to be modified according to high-risk lobes.
The Institutional Review Board of Kanazawa Medical University approved the protocol of this retrospective study (approval number: I392), and written informed consent was obtained from all patients.
尽管国家临床数据库(RC-NCD)的风险计算器已被广泛用于预测日本患者死亡率和主要并发症的发生,但尚未证明计算出的 RC-NCD 风险评分与死亡率和严重并发症的实际发生之间存在相关性。
收集了 585 例接受非小细胞肺癌肺切除术患者的临床资料,分析了术后发病率的危险因素,以验证 RC-NCD 的有效性。
本研究中,哮喘(p=0.02)、营养淋巴细胞比(p=0.04)和肺叶(p<0.01)共存是术后发病率的显著危险因素,而预计肺活量百分比(p<0.01)、肺叶(p=0.03)和手术类型(p=0.01)是严重术后发病率的显著危险因素。此外,在接受肺叶切除术的患者中,哮喘(p=0.01)和肺叶(p<0.01)共存是术后发病率的显著危险因素。同时,男性(p=0.01)、高 BMI(p<0.01)、低肺活量(p=0.04)和肺叶(p=0.03)是严重术后发病率的显著危险因素。
鉴于肺叶是接受肺切除术的患者术后发病率和接受肺叶切除术的患者严重术后发病率的显著危险因素,需要根据高危肺叶对术后发病率的 RC-NCD 进行修改。
金泽医科大学伦理委员会批准了这项回顾性研究的方案(编号:I392),并从所有患者处获得了书面知情同意。